Eversept Partners, LP
Eversept Partners, L.P. is a New York-based hedge fund manager specializing in alpha-driven, low-net, fundamentally oriented, valuation-disciplined healthcare equity long/short strategies. The firm invests across all sub-sectors and market caps in the global healthcare industry, employing a long-term, valuation-driven research process and concentrating capital in its highest conviction ideas. The firm also opportunistically invests outside healthcare and may use leverage, options, and event-driven strategies.
Investment Strategy
Eversept employs a fundamental, long-term, valuation-driven approach, focusing on both long and short equity positions in healthcare and, opportunistically, other sectors. The firm is not constrained by diversification requirements and may concentrate assets in a limited number of high-conviction positions. Strategies include exploiting inefficiencies, short-term anomalies, and event-driven opportunities. The firm uses leverage, options, ETFs, convertible securities, and may invest in private placements or across geographies and asset classes as opportunities arise.
Top Holdings
Equity Positions (66)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
N NTRA | NATERA INC | 12.37% | $134.5M | 796,375 | $44.18 | $168.94 | +$8.2M |
G GSK | GSK PLC | 7.92% | $86.1M | 2,242,388 | $34.72 | $38.40 | -$15.5M |
V VERA | VERA THERAPEUTICS INC | 5.16% | $56.1M | 2,383,055 | $17.49 | $23.56 | +$10.5M |
P PCVX | VAXCYTE INC | 3.88% | $42.2M | 1,298,514 | $39.10 | $32.51 | +$21.2M |
H HCA | HCA HEALTHCARE INC | 3.52% | $38.3M | 99,983 | $290.12 | $383.10 | -$14.4M |
Options Positions (1)
| Ticker | Security | Action | Type | Notional Value | Contracts | Underlying Price | Premium Paid | Change (Contracts) | Change (Value) |
|---|---|---|---|---|---|---|---|---|---|
Q QQQ | INVESCO QQQ TR | Bought | Put | $95.0M | 1,722 | $551.64 | $435.74 | +486 | +$37.0M |